Brand dynamics

Group Real-Time Dynamics And Cutting-Edge Information In The Field Of One Health

Health Yuan: Precision poverty alleviation during the fight against the epidemic

Published Time:

2020-03-18

On March 6th, a meeting on decisively winning the battle against poverty emphasized that the complete eradication of rural poverty by 2020, under the current standards, is a solemn promise made to the people of the whole country and must be achieved on schedule. The meeting's address clarified the direction for poverty alleviation efforts, strengthened the confidence of cadres and the masses in achieving a complete victory, and triggered a strong response. During the current crucial stage of epidemic prevention and control, the whole country is working hard to "fight the epidemic," while also striving to achieve many goals that accompany or intertwine with the epidemic, including consolidating the achievements of poverty reduction while supporting the prevention and control of the novel coronavirus pneumonia epidemic, completely winning the battle against poverty, and achieving a double victory in "fighting the epidemic" and "fighting poverty."

 

Recently, in supporting the fight against the novel coronavirus pneumonia epidemic, Joincare Pharmaceutical Group Industry Co., Ltd. (hereinafter referred to as "Health Yuan Group") has not forgotten its original intention of assistance and has practiced its mission and responsibility in targeted poverty alleviation. Following the donation of materials and funds worth a total of 22 million yuan (10 million yuan from Health Yuan Group and 12 million yuan from its subsidiary, Lizhu Pharmaceutical Group Co., Ltd.), the company donated a total of 3.4 million yuan worth of "Bena" (Meropenem for Injection) to the China Red Cross Foundation, leveraging its corporate strengths. Part of these materials will be directly donated to Xianghai Township, Tongyu County, Baicheng City, Jilin Province, to alleviate the shortage of medical supplies in this impoverished area during the epidemic prevention and control efforts.

 

It is understood that while supporting epidemic prevention and control, Health Yuan Group's poverty alleviation work, which is comprehensively promoted, has been proceeding in an orderly manner. The chronic disease poverty alleviation project of Health Yuan & Lizhu Group officially landed in the villages surrounding the Xianghai Nature Reserve in December last year, donating medicines worth 1 million yuan to 16 villages, benefiting a total of 800 villagers, and assisting in their medical poverty alleviation. Since the outbreak of the novel coronavirus pneumonia epidemic, while focusing on epidemic prevention and control, Health Yuan Group has not relaxed its efforts in targeted poverty alleviation, achieving both epidemic prevention and control and targeted poverty alleviation without compromising either.

 

Public information shows that the "Bena" (Meropenem for Injection) donated by Health Yuan Group is suitable for adults and children with infections caused by single or multiple bacteria sensitive to meropenem, including pneumonia, urinary tract infections, gynecological infections, skin and soft tissue infections, meningitis, and sepsis. It is understood that these materials will effectively alleviate the pressure on drug supply in the recipient areas during the current epidemic.

 

The novel coronavirus pneumonia epidemic has brought new challenges to the company's targeted poverty alleviation work this year. Achieving complete poverty alleviation is a firm commitment made by the Party to the people. As a responsible listed company, Health Yuan will make greater efforts, with a clearer approach and more precise measures, to work together to win the battle against poverty and work hand in hand with governments at all levels to create "targeted poverty alleviation power."